|  | 
  
 | 
  
 |   Corporate Profile:  Dyax
 
  
  
  
 | Summary: |   
 | Dyax 
 is involved in the discovery, development, and commmercialization 
 of fully human monoclonal antibodies as well as 
 small proteins and peptides. |  
 
  
 | Address (HQ): |   
 | 55 Network Drive Burlington, MA 01803
 |  
 
  
 | Phone #'s (HQ): |   
 | Main | (617) 225-2500 |   
 | Human 
 Resources | not known |   
 | Investor 
 Relations | (617) 250-5744 |  
 
  
 | Fax #'s (HQ): |   
 | Main | (617) 225-2501 |   
 | Human 
 Resources | not known |   
 | Investor 
 Relations | (617) 225-2501 |  
 
 
 
  
 | Financial 
 information: |   
 | DYAX |  
 
 
 
  
 | Issued United States patents: |   
 | Issued U.S. patents: 1976-present: patent 
 link. |  
 
 
 | Filed United States patent applications: |  
 | Filed U.S. patent applications: 2001-present: patent 
 link. |  
 
 
 | Publications on PubMed: |  
 | Scientific publications on PubMed with an author from the company: publications 
 link. |  
 
  |  |  |